Skip to main content
Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder OCM.72

Target:

Sub-type:

Host:

Application: Ex vivo drug-sensitivity profiling; OCM-derived xenograft generation

Cat. #161891

 £575.00
£575.00

You may be interested in…

  • Placeholder

    OCM.246

     £575.00 OCM.246

    Cat. #161894

    Organism: Human

    Tissue: Ovary. NOTE: The precursor of a substantial proportion of HGSOC is likely to be serous tubal intraepithelial carcinoma in the fimbriae of the fallopian tubes

    Cancer Type: Gynaecologic cancer

    View Tool
    £575.00Add to Cart
  • Placeholder

    OCM.191

     £575.00 OCM.191

    Cat. #161893

    Organism: Human

    Tissue: Ovary. NOTE: The precursor of a substantial proportion of HGSOC is likely to be serous tubal intraepithelial carcinoma in the fimbriae of the fallopian tubes

    Cancer Type: Gynaecologic cancer

    View Tool
    £575.00Add to Cart
  • Placeholder

    OCM.109

     £575.00 OCM.109

    Cat. #161892

    Organism: Human

    Tissue: Ovary. NOTE: The precursor of a substantial proportion of HGSOC is likely to be serous tubal intraepithelial carcinoma in the fimbriae of the fallopian tubes

    Cancer Type: Gynaecologic cancer

    View Tool
    £575.00Add to Cart
  • Placeholder

    OCM.66-1

     £575.00 OCM.66-1

    Cat. #161890

    Organism: Human

    Tissue: Ovary. Ovarian/primary peritoneal. NOTE: The precursor of a substantial proportion of HGSOC is likely to be serous tubal intraepithelial carcinoma in the fimbriae of the fallopian tubes

    Cancer Type: Gynaecologic cancer

    View Tool
    £575.00Add to Cart

Cart totals

Subtotal £575.00
Shipping

Shipping options will be updated during checkout.

Total £785.00
Proceed to checkout

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.